Temasek Holdings Dumps More of Celltrion

Posted on 10/23/2018


On October 22, 2018, Singapore’s Temasek Holdings, through its sovereign wealth enterprise (SWE) Ion Investments, entered into its second block deal in selling shares in Celltrion, a South Korean bio-pharmaceutical company. In a block deal managed by Credit Suisse, Temasek sold off 3,391,700 shares in Celltrion in a transaction worth an estimated 865 billion KRW. […]